Softhale is a pharmaceutical company based in Diepenbeek, Belgium, specializing in the development of inhalable respiratory products for the medical treatment of various conditions such as Asthma and COPD. Their focus lies on product development, formulation development, and analytical capabilities, led by international industry experts supported by external service providers. Softhale aims to provide high-quality yet affordable alternative treatment options to established inhalation products.

They also plan to use their inhaler platform technology for innovative inhalation products by combining approved drugs with the Soft Mist Inhaler or delivering New Chemical Entities (NCE) through partnerships. The rise in chronic respiratory diseases continues to drive the industry, and Softhale is actively involved in development activities for regulatory submission. Their team consists of medical, pharmaceutical, and consumer product experts, ensuring a thorough approach to their work.

Softhale's mission is to provide innovative and accessible inhalation medications for patients worldwide